ArticleScientific reports2023

Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson's disease in diabetic patients.

Yu-Hsuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.